The negative formulary approach. State plans with this approach have listed drugs for which substitution by another drug is not allowed. This indicates that medical and pharmacy boards have identified bioequivalence problems for the listed drug that may render a substitution harmful.
Welcome to Wikipedia. Although everyone is welcome to make constructive contributions to Wikipedia, at least one of your recent edits, such as the one you made to Blue Cross & Blue Shield of Rhode Island Headquarters, did not appear to be constructive and has been reverted. Please use the sandbox for any test edits you would like to make, and read the welcome page to learn more about contributing constructively to this encyclopedia. Thank you.--Loodog (talk) 21:04, 21 April 2009 (UTC)
This is the discussion page for an IP user, identified by the user's IP address. Some IP addresses change periodically, and may be shared by several users. If you are an IP user, you may create an account or log in to avoid future confusion with other IP users. Registering also hides your IP address.